INCREASED INPATIENT UTILIZATION FOLLOWING COLECTOMY IN ULCERATIVE COLITIS IN THE MEDICARE POPULATION
Author(s)
H. C. Thompson, MS, MBA, Associate Director1, M. R. Kugel, MS, Consultant2, M. I. Rahman, MD, MPH, Senior Director of Pharmacoepidemiology1, G J Watson, MS, Consultant2, O Dabbous, MD, MPH, Associate Director1, B Tang, MD, PhD, Associate Director11Centocor, Inc, Horsham, PA, USA; 2 The Moran Company, Arlington, VA, USA
OBJECTIVES: Examine inpatient hospital utilization, following colectomy, in patients with ulcerative colitis (UC) covered by Medicare. METHODS: A retrospective analysis was conducted using claims from the Medicare Standard Analytic Files (SAF) 5% sample database between January 1, 2001 and December 31, 2005. Patients with UC were identified using diagnostic codes (ICD-9 codes 556.x) and were limited to those with a procedure code indicating colectomy (45.7x), and a diagnosis of UC prior to that date. Patients with a subsequent diagnosis of Crohn's disease were eliminated from this analysis. The first procedure was chosen if the beneficiary had multiple 45.7x procedures (these are partial excisions, so a beneficiary could have multiple procedures over time). The study design consisted of a 12-month pre- and 12-month post-colectomy period during which continuous enrollment was required. Inpatient hospital costs and resource utilization were evaluated 12-months before and 12-months after the quarter in which the colectomy occurred. All costs are presented in 2005 US dollars. RESULTS: A total of 905 patients with UC who had a claim for colectomy were included in the analysis. Total inpatient costs ($19,778 vs. $23,765) and average length of stay (ALOS) (15.2 days vs. 18.3 days) increased following colectomy, while mean number of admissions did not increase significantly. The same trend was seen in UC-related costs ($6,957 vs. $12,422) and lengths of stay (7.6 days vs. 11.7 days). CONCLUSION: Inpatient hospital utilization and subsequent costs increased during the 12-month period following colectomy in the Medicare population. Additional analyses are needed to determine the extent of these services and reasons for increased inpatient utilization.
Conference/Value in Health Info
2007-10, ISPOR Europe 2007, Dublin, Ireland
Value in Health, Vol. 10, No. 6 (November/December 2007)
Code
PGI17
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Gastrointestinal Disorders